AF
RGNX icon

Allworth Financial’s Regenxbio RGNX Stock Holding History

Allworth Financial’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2K Sell
851
-375
-31% -$3.11K ﹤0.01% 3699
2026
Q1 		$10.3K Sell
1,226
-327
-21% -$3.44K ﹤0.01% 3479
2025
Q4 		$22.4K Buy
1,553
+415
+36% +$5.17K ﹤0.01% 2742
2025
Q3 		$11K Buy
1,138
+1,073
+1,651% +$9.49K ﹤0.01% 3083
2025
Q2 		$534 Hold
65
– – ﹤0.01% 4120
2025
Q1 		$598 Buy
+65
New +$484 ﹤0.01% 3632
2024
Q4 		– Sell
-197
Closed -$2.07K – 4029
2024
Q3 		$2.07K Buy
+197
New +$2.4K ﹤0.01% 2958

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Allworth Financial's RGNX Position: Q2 2026 in Review

Allworth Financial reduced its Regenxbio (RGNX) stake by 31% in Q2 2026, selling an estimated $3.11K and leaving 851 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3699.

Allworth Financial first reported a position in RGNX in Q3 2024 and has held it in 7 quarters since. The position peaked at $22.4K in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Allworth Financial held 851 shares of Regenxbio worth $10.2K as of Q2 2026.
  • Allworth Financial sold 375 Regenxbio shares in Q2 2026, an estimated $3.11K.
  • Regenxbio made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3699 holding.
  • Allworth Financial first reported a position in Regenxbio in Q3 2024 and has held it in 7 quarters since.
  • Allworth Financial's Regenxbio position peaked at $22.4K in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.